10-Q/A

03/02 AMENDED 10Q

Company: LIGAND PHARMACEUTICALS INC
Filed: July 1, 2002
Period of Report: March 31, 2002
Accession Number: 0000886163-02-000016

View Document ↗ View on SEC.gov ↗